Award
National Institute of Allergy and Infectious Diseases 1R21AI194022-01
Human normal tissue patient-derived organoids for pre-screening GI radiation countermeasure drugs
Recipient
Not specified
Award Amount
$164,500.00
Ceiling
$164,500.00
Awarded
August 19, 2025
Identifier
1R21AI194022-01
Award for developing and validating human tissue organoids to screen gastrointestinal radiation countermeasure drugs, funded by NIH/NIAID with a duration from August 19, 2025, to July 31, 2027, and an award amount of approximately $164,500.
Description
The project aims to develop and validate human tissue organoids for screening radiation countermeasures. The project involves high-throughput screening and molecular analysis.